SCHEMBL14520856

SCHEMBL14520856

COc1cccc(N(C(C)CCN2CCC(C)CC2)S(=O)(=O)c2cccc(C)c2)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR7 P34969 9/20 0.67
▸ DRD2 P14416 2/20 0.67
▸ HTR1D P28221 2/20 0.67
▸ DRD3 P35462 2/20 0.67
▸ TMEM97 Q5BJF2 1/20 0.47
▸ SIGMAR1 Q99720 1/20 0.47
▸ HTR1A P08908 2/20 0.45
▸ HTR1B P28222 1/20 0.45
▸ PSEN1 P49768 1/20 0.43
▸ PSEN2 P49810 1/20 0.43
▸ APH1B Q8WW43 1/20 0.43
▸ NCSTN Q92542 1/20 0.43
▸ APH1A Q96BI3 1/20 0.43
▸ PSENEN Q9NZ42 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ HRH3 Q9Y5N1 2/20 0.41
▸ CCR5 P51681 1/20 0.40
▸ HTR2A P28223 1/20 0.40
▸ HTR2C P28335 1/20 0.40
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14520859 0.88 HTR7 (0.51) HTR7DRD2HTR1DDRD3TMEM97
SCHEMBL14520858 0.87 HTR7 (0.50) HTR7DRD2HTR1DDRD3TMEM97
SCHEMBL14520860 0.86 HTR7 (0.48) HTR7DRD2HTR1DDRD3TMEM97
SCHEMBL14520857 0.82 HTR7 (0.67) HTR7DRD2HTR1DDRD3SIGMAR1
Sb-258719 SCHEMBL2471088 0.80 HTR7 (1.00) HTR7DRD2HTR1DDRD3HTR1A
Sb-258719 SCHEMBL2471089 0.80 HTR7 (1.00) HTR7DRD2HTR1DDRD3HTR1A
Sb-258719 SCHEMBL29774472 0.80 HTR7 (1.00) HTR7DRD2HTR1DDRD3HTR1A
Sb-258719 SCHEMBL3688509 0.80 HTR7 (0.98) HTR7DRD2HTR1DDRD3TMEM97
SCHEMBL14520861 0.79 HTR7 (0.50) HTR7DRD2HTR1DDRD3TMEM97
SCHEMBL14520864 0.72 HTR7 (0.53) HTR7DRD2HTR1DDRD3SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070088052-A1 Sulfonamide derivatives as 5ht7 receptor antagonists ASTON UNIVERSITY (GB) 2007-04-19 — — US disclosed
US-20070088052-A1 Sulfonamide derivatives as 5ht7 receptor antagonists ASTON UNIVERSITY (GB) 2007-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070088052-A1 Sulfonamide derivatives as 5ht7 receptor antagonists HTR7, HTR2B, HTR2C HTR7 1/4885DRD2 57/4885HTR1D 22/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback